CLINICAL TRIAL SUMMARY

MDACC Study No:2009-0577 (clinicaltrials.gov NCT No: Not Applicable Clinical Trial)
Title:Concurrent versus sequential smoking and physical activity intervention for cancer survivors
Principal Investigator:Jan Blalock
Treatment Agent:Behavioral intervention; Bupropion; Exercise; Nicotine; Physical Assessment; Questionnaire; Survey; Varenicline
Study Status:Closed
Study Description:The goal of part 2 of this 2-part research study is to compare different
schedules of counseling when given to cancer patients who smoke cigarettes.
Researchers want to learn which type of counseling may be more effective in
helping cancer survivors to stop smoking and increase physical activity

Hide details for General InformationGeneral Information

Disease Group:Breast; Colorectum; Prostate
Phase of Study:N/A
Treatment Agents:Behavioral intervention
Bupropion
Exercise
Nicotine
Physical Assessment
Questionnaire
Survey
Varenicline
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:No hospitalization is required
Supported By:Institutional Multidisciplinary Research Program
Return Visit:Participants will visit MDACC 1 or 2 times pre-treatment, at 14 weeks, and 6
months to complete full assessments.
Home Care:Participants will exercise at home. Counseling sessions will occur at home via
webcam, or by telephone in the case of webcam equipment failure.


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Jan Blalock
Dept:Behavioral Science
For Clinical Trial Enrollment:713-745-1728
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults